Transforming growth factor-β in benign and malignant prostate

Prostate

Volumn 39, Issue 4, 1999, Pages 285-290

  Lee, Chung ^a   Sintich, Sharon M ^a   Mathews, Eric P ^a   Shah, Ali H ^a   Kundu, Shilajit D ^a   Perry, Kent T ^a   Cho, Jin Seon ^a,b   Ilio, Kenneth Y ^a   Cronauer, Marcus V ^a   Janulis, Lynn ^a   Sensibar, Julia A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Hallym University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; GROWTH REGULATION; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN DETERMINATION; SMOOTH MUSCLE FIBER;

ANDROGENS; ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PROGNOSIS; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 0033152596     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19990601)39:4<285::AID-PROS9>3.0.CO;2-7     Document Type: Article

References (50)

1. Lee C. Physiology of castration-induced regression in rat prostate. In: Murphy G, Sandberg AA, Karr JP, editors. The prostatic cell: structure and function. New York: Alan R Liss, Inc.; 1981. p 145-159.
2. Isaacs JT. Antagonistic effect of androgen on prostatic cell death. Prostate 1984;5:545-557.
3. Lee C. Role of androgen in prostate growth and regression: stromal-epithelial interaction. Prostate [Suppl] 1986;6:52-56.
4. Steiner MS, Transforming growth factor-β and prostate cancer. World J Urol 1995;13:329-336.
5. Lee C. Biology of the prostatic ductal system. In: Nez R, editor. Prostate: clinical and basic aspects. Boca Raton: CRC Press; 1997. p 53-71..
6. Jakowlew SB, Dillard PJ, Kondaiah P, Sporn MB, Roberts AB. Complementary deoxyribonucleic acid cloning of a novel transforming growth factor-β messenger ribonucleic acid from chick embryo chondrocytes. Mol Endocrinol 1988;2:747-755.
7. Kondaiah P, Sands MJ, Smith JM, Fields A, Roberts AB, Sporn MB, Melton DA. Identification of a novel transforming growth factor-beta (TGF-β5) mRNA in Xenopus laevis. J Biol Chem 1990; 265:1089-1093.
8. Derynck R, Jarret JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Geoddel DV. Human transforming growth factor-β complementary DNA sequences and expression in normal and transformed cells. Nature 1985;316:701-705.
9. Madison L, Webb NR, Rose TM, Marquardt H, Ikeda T, Twardzik D, Seyedin S, Purchio AF. Transforming growth factor-beta 2: cDNA cloning and sequence analysis. DNA 1988;7;1-8.
10. Sutkowski DM, Fong C-J, Sensibar JA, Rademaker AW, Sherwood ER, Kozlowski JM, Lee C. Interaction of epidermal growth factor and transforming growth factor-β1 in human prostatic epithelial cells in culture. Prostate 1992;21:133-143.
11. Wilding G. Response of prostate cancer cells to peptide growth factor: transforming growth factor-β. Cancer Surv 1991;11:147-163.
12. Cheifetz S, Hernandez H, Laiho M, ten Dijke P, Iwata KK, Massague J. Distinct transforming growth factor-β receptor subsets as determinants of cellular responsiveness to three TGF-β isoforms. J Biol Chem 1990;265:20533-20538.
13. Cheifetz S, Ling N, Guillemin R, Massague J. A surface component on GH3 pituitary cells that recognizes transforming growth factor-β, activin and inhibin. J Biol Chem 1988;263:17225-17228.
14. Lopez-Casillas F, Chiefetz S, Doody J, Andres JL, Lane WS, Massague J. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor. Cell 1991;67:785-795.
15. Lopez-Casillas F, Wrana JL, Massague J. Betaglycan presents ligand to the TGF signaling receptor. Cell 1993;73:1435-1444.
16. Rodriguez C, Chen F, Weinberg RA, Lodish HF. Cooperative binding of transforming growth factor (TGF)-β2 to the TβR-I and II TGF-β receptors. J Biol Chem 1995;270:15919-15922.
17. Sankar M, Mahooti-Brooks N, Centrella M, McCarthy TH, Madri JA. Expression of transforming growth factor TβR-III receptor in vascular endothelial cells increase their responsiveness to transforming growth factor 2. J Biol Chem 1995;270:2769-2775.
18. Kingsley DM. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms [review]. Genes Dev 1994;8:133-146.
19. Wrana JL, Attisano L, Wieser R, Ventura F, Massague J. Mechanism of activation of the TGF-β receptor. Nature 1994;370:341-347.
20. Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Lang S, Kato M, Oefelein MG, Miyazono K, Kozlowski JM, Lee C. Loss of expression of transforming growth factor-β receptors type I and type II correlates with tumor grade in human prostate cancer tissues. Clin Cancer Res 1996;2:1255-1261.
21. Kim IY, Ahn HJ, Lang S, Oefelein MG, Oyasu R, Kozlowski JM, Lee C. Loss of expression of transforming growth factor-β receptors is associated with poor prognosis in prostate cancer patients. Clin Cancer Res 1998;4:1625-1630.
22. Martikainen P, Kyprianou N, Isaacs JT. Effect of transforming growth factor-β1 on proliferation and death of rat prostatic cells. Endocrinology 1990;127:2963-2968.
23. Nemeth JA, Sensibar JA, White RR, Zelner DJ, Kim IY, Lee C. Prostatic ductal system in rats: tissue-specific expression and regional variation in stromal distribution of transforming growth factorβ1. Prostate 1997;33:64-71.
24. Kim IY, Ahn HJ, Zeiner DJ, Park L, Sensibar JA, Lee C. Expression and localization of transforming growth factor-β receptors type I and II in the rat ventral prostate during regression. Mol Endocrinol 1996;10:107-115.
25. Lee C, Sensibar JA, Dudek SM, Hiipakka RA, Liao S. Prostatic ductal system in rats: regional variation in morphological and functional activities. Biol Reprod 1990;43:1079-1086.
26. Nemeth JA, Lee C. The prostatic ductal system in rats: regional variation in stromal organization. Prostate 1996;28:124-128.
27. Ilio KY, Sensibar JA, Lee C. Effect of TGF-β1, TGF-α and EGF on cell proliferation and cell death in rat ventral prostate epithelial cells in culture. J Androl 1995;16:482-490.
28. Sensibar JA, Griswold MD, Sylvester SR, Buttyan R, Bardin CW, Cheng CY, Dudek S, Lee C. Prostatic ductal system in rats: regional variation in localization of an androgen-repressed gene product, sulfated glycoprotein-2. Endocrinology 1991;128:2091-2102.
29. Kyprianou N, Isaacs JT. Expression of transforming growth factor β in the rat ventral prostate during castration-induced programmed cell death. Mol Endocrinol 1989;3:1515-1522.
30. Nemeth JA, Sensibar JA, Lee C. Changes in TGF-β localization in the rat prostatic ductal system during castration-induced regression. Proceedings 77th Annual Meeting for the Endocrine Society, Washington, DC, June 14-17, 1995 (abstract P1-361).
31. Kassen A, Sutkowski DM, Ahn HJ, Sensibar JA, Kozlowski JM, Lee C. Stromal cells of human prostate: initial isolation and characterization. Prostate 1996;28:89-97.
32. Eghbali M, Tomek R, Woods C, Bhambi B. Cardiac fibroblasts are predisposed to convert into myocyte phenotype: specific effect of transforming growth factor-β. Proc Natl Acad Sci USA 1991;88:795-799.
33. Timme TL, Truong LD, Merz VW, Krebs T, Kadmon D, Flanders KC, Park SH, Thompson TC. Mesenchymal-epithelial interactions and transforming growth factor-β expression during mouse prostate morphogenesis. Endocrinology 1994;134:1039-1045.
34. Franks LM. Benign nodular hyperplasia of the prostate: a review. Annu Rev Coll Surg Engl 1954;14:92-106.
35. peehl DM, Sellers RG. Induction of smooth muscle cell phenotypes in cultured human prostatic stromal cells. Exp Cell Res 1997;232:208-215.
36. Muir GH, Butta A, Shearer RJ, Fisher C, Dearnaley DP, Flanders KC, Sporn MB, Colletta AA. Induction of transforming growth factor beta in hormonally treated human prostate cancer. Br J Cancer 1994;69:130-134.
37. Ahn HJ, Kim IY, Sensibar JA, Lee C. Effect of androgen on the growth and production of keratinocyte growth factor and transforming growth factor-β's in human prostate stromal cells. J Urol 1995;153:160.
38. Lamm MLG, Sintich SM, Lee C. A proliferative effect of transforming growth factor-β1 on a human prostate cancer cell line, TSU-Prl. Endocrinology 1998;139:787-790.
39. Steiner MS, Barrack ER. Transforming growth factor-β1 over-production in prostate cancer: effects on growth in vivo and in vitro. Mol Endocrinol 1992;6:15-25.
40. Barrack ER. TGF-β on prostate cancer: a growth inhibitor that can enhance tumorigenicity. Prostate 1997;31:61-70.
41. Isaacs JT, Isaacs WB, Feitz WF, Scheres J. Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers. Prostate 1986;9:261-281.
42. Isaacs JT, Yu GW, Coffey DS. The characterization of a newly identified, highly metastatic variety of Dunning R 3327 rat prostatic adenocarcinoma system: the MATLyLu tumor. Invest Urol 1981;9:20-23.
43. Dunning WF, Prostate cancer in the rat. NCI Monogr 1963;12: 351-369.
44. Vieweg J, Heston WD, Gilboa E, Fair WR. An experimental model simulating local recurrence and pelvic lymph node metastasis following orthotopic induction of prostate cancer. Prostate 1994;24:291-298.
45. Ignotz RA, Massague J. Transforming growth factor β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986;261: 4337-4345.
46. Rizzino A. Transforming growth factor-β: multiple effects on cell differentiation and extracellular matrices. Dev Biol 1988;130: 411-422.
47. Yang EY, Moses HL. Transforming growth factor β1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 1990;111:731-741.
48. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-β. Annu Rev Immunol 1998;16:137-161.
49. Goodwin S, Kundu S, Janulis L, Lee C. Inhibition of TGF-β1 production in the MATLyLu cell line is associated with increased cellular proliferation in culture. Proceedings 7th Annual SBUR Fall Symposium with the ESUOE, Pacific Grove, CA, December 10-14, 1997.
50. Mathews EP, Yang T, Goodwin S, Lee C. Inverse correlation between cellular proliferation rates and TGF-β1 production. Abstract presented at 8th Annual SBUR Fall Symposium, Prouts Neck, ME, November 12-15, 1998.